MA35269B1 - Nouveaux dérivés de phtalazinone-pyrrolopyrimidinecarboxamide - Google Patents

Nouveaux dérivés de phtalazinone-pyrrolopyrimidinecarboxamide

Info

Publication number
MA35269B1
MA35269B1 MA36689A MA36689A MA35269B1 MA 35269 B1 MA35269 B1 MA 35269B1 MA 36689 A MA36689 A MA 36689A MA 36689 A MA36689 A MA 36689A MA 35269 B1 MA35269 B1 MA 35269B1
Authority
MA
Morocco
Prior art keywords
pyrrolopyrimidinecarboxamide
phthalazinone
derivatives
compounds
type
Prior art date
Application number
MA36689A
Other languages
English (en)
French (fr)
Inventor
Thomas Stengel
Thomas Maier
Alexander Mann
Josef Stadlwieser
Dieter Flockerzi
Andreas Pahl
Ewald Benediktus
Manuela Hessmann
Tobias Kanacher
Ragna Hussong
Christof Zitt
Hans Christof Holst
Rolf-Peter Hummel
Martin Viertelhaus
Hermann Tenor
Torsten Dunkern
Armin Hatzelmann
Christian Hesslinger
Original Assignee
Akeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44764312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA35269(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akeda Gmbh filed Critical Akeda Gmbh
Publication of MA35269B1 publication Critical patent/MA35269B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA36689A 2011-06-17 2014-01-16 Nouveaux dérivés de phtalazinone-pyrrolopyrimidinecarboxamide MA35269B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11170440 2011-06-17
PCT/EP2012/061084 WO2012171900A1 (en) 2011-06-17 2012-06-12 Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives

Publications (1)

Publication Number Publication Date
MA35269B1 true MA35269B1 (fr) 2014-07-03

Family

ID=44764312

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36689A MA35269B1 (fr) 2011-06-17 2014-01-16 Nouveaux dérivés de phtalazinone-pyrrolopyrimidinecarboxamide

Country Status (22)

Country Link
US (2) US20140112945A1 (https=)
EP (1) EP2721030B1 (https=)
JP (1) JP5980318B2 (https=)
KR (1) KR20140037195A (https=)
CN (1) CN103582644B (https=)
AR (1) AR086915A1 (https=)
AU (1) AU2012269133A1 (https=)
BR (1) BR112013031791A2 (https=)
CA (1) CA2837248A1 (https=)
CL (1) CL2013003556A1 (https=)
CO (1) CO6852074A2 (https=)
CR (1) CR20130656A (https=)
DO (1) DOP2013000298A (https=)
EA (1) EA023713B1 (https=)
EC (1) ECSP13013076A (https=)
ES (1) ES2564882T3 (https=)
MA (1) MA35269B1 (https=)
MX (1) MX2013014888A (https=)
PE (1) PE20140648A1 (https=)
PH (1) PH12013502546A1 (https=)
TN (1) TN2013000439A1 (https=)
WO (1) WO2012171900A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170132880A (ko) 2015-04-09 2017-12-04 갈데르마 소시에떼아노님 약학 조성물 및 이의 용도
HRP20190088T1 (hr) 2015-04-09 2019-03-22 Galderma Sa Ekstrakt iz prirodnog indiga i postupak njegove priprave
EP3280428A1 (en) 2015-04-09 2018-02-14 Galderma S.A. Antibacterial indigo naturalis or indigo-producing plant extract and use thereof
EP3215169A1 (en) * 2015-04-09 2017-09-13 Galderma S.A. Treatment of atopic dermatitis with indigo naturalis or indigo producing plant extract
US12383547B2 (en) 2020-07-01 2025-08-12 Vanderbilt University Methods of treatment for a kidney disease

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE407028T1 (de) 1989-05-31 1994-03-17 Fisons Plc Medikament und Inhalationsvorrichtung dafür.
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
AU654813B2 (en) 1990-03-23 1994-11-24 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
JP2769925B2 (ja) 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of medicament formulations
TR199901653T2 (xx) * 1997-01-15 1999-10-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Fitalazinonlar.
JP2002506856A (ja) * 1998-03-14 2002-03-05 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング フタラジノンｐｄｅｉｉｉ／ｉｖ阻害剤
CN1150890C (zh) 1998-08-04 2004-05-26 杰格研究股份公司 药用气溶胶制剂
US6397838B1 (en) 1998-12-23 2002-06-04 Battelle Pulmonary Therapeutics, Inc. Pulmonary aerosol delivery device and method
JP4677102B2 (ja) 1999-04-23 2011-04-27 バテル・メモリアル・インスティテュート エーロゾル給送装置及びエーロゾル小滴を給送する方法
AU777169B2 (en) 1999-04-23 2004-10-07 Battelle Memorial Institute High mass transfer electrosprayer
NZ522882A (en) * 2000-06-05 2004-07-30 Altana Pharma Bv Pyridazinone compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors
CA2425035A1 (en) 2000-10-09 2002-04-18 3M Innovative Properties Company Medicinal aerosol formulations
EE05386B1 (et) 2001-02-15 2011-02-15 ALTANA�Pharma�AG Ftalasinoon-piperidinoderivaadid,ÁnendeÁkasutamineÁjaÁravim
NZ529221A (en) 2001-04-25 2005-04-29 Altana Pharma Ag Phthalazinones with PDE-inhibiting properties for treatment of airway disorders and other inflammatory conditions
AU2003255376A1 (en) 2002-08-10 2004-03-11 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
CA2494613C (en) 2002-08-10 2011-06-28 Altana Pharma Ag Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
WO2004018451A1 (en) 2002-08-10 2004-03-04 Altana Pharma Ag Pyridazinone-derivatives as pde4 inhibitors
WO2004062671A2 (en) * 2003-01-14 2004-07-29 Altana Pharma Ag Pde4 inhibitors for the treatment of neoplasms of lymphoid cells
WO2005075457A1 (en) 2004-02-04 2005-08-18 Altana Pharma Ag Phthalazinone-derivatives as pde4 inhibitors
EP1716133B1 (en) 2004-02-04 2008-03-26 Nycomed GmbH 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
AR070454A1 (es) * 2008-02-27 2010-04-07 Nycomed Gmbh Pirrolopirimidincarboxamidas y composiciones farmaceuticas que las comprenden
AR077898A1 (es) * 2009-08-26 2011-09-28 Nycomed Gmbh Metilpirrolopirimidincarboxamidas

Also Published As

Publication number Publication date
CA2837248A1 (en) 2012-12-20
JP2014517021A (ja) 2014-07-17
US20160108049A1 (en) 2016-04-21
ES2564882T3 (es) 2016-03-29
WO2012171900A1 (en) 2012-12-20
EA023713B1 (ru) 2016-07-29
AU2012269133A1 (en) 2014-01-30
BR112013031791A2 (pt) 2017-01-31
EP2721030B1 (en) 2015-12-16
ECSP13013076A (es) 2014-01-31
EA201400001A1 (ru) 2014-05-30
CN103582644A (zh) 2014-02-12
KR20140037195A (ko) 2014-03-26
EP2721030A1 (en) 2014-04-23
JP5980318B2 (ja) 2016-08-31
DOP2013000298A (es) 2014-03-31
MX2013014888A (es) 2014-02-27
PH12013502546A1 (en) 2014-01-27
CL2013003556A1 (es) 2014-06-13
CN103582644B (zh) 2016-07-20
TN2013000439A1 (en) 2015-03-30
PE20140648A1 (es) 2014-05-30
US20140112945A1 (en) 2014-04-24
CR20130656A (es) 2014-02-18
AR086915A1 (es) 2014-01-29
CO6852074A2 (es) 2014-01-30

Similar Documents

Publication Publication Date Title
UY36907A (es) Nuevas carboxamidas de acción microbiocida
EA201000113A1 (ru) Пиразольные соединения
EA201100447A1 (ru) Органические соединения
EA201070186A1 (ru) Способы и соединения, предназначенные для получения ингибиторов котранспортера натрий-глюкозы 2 типа
EA201200018A1 (ru) Триазольные соединения, несущие серосодержащий заместитель
CU24039B1 (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
EA201170384A1 (ru) Пиррольные соединения
MA37142A3 (fr) Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine
ME03065B (me) 1,2,5-oksadiazoli kao inhibitori indolamin 2,3-dioksigenaze
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
MA35245B1 (fr) Pyridin-2-amides utiles comme agonistes de cb2
UA108219C2 (uk) Протипаразитарні дигідроазолові сполуки та композиція, яка їх містить (варіанти)
EA200970913A1 (ru) 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
MA35269B1 (fr) Nouveaux dérivés de phtalazinone-pyrrolopyrimidinecarboxamide
MA35086B1 (fr) Compose de triazolopyridine
EA201000550A1 (ru) Производные тиазола
MA38645B1 (fr) Nouveaux inhibiteurs de cyp17/antiandrogènes
EA201170997A1 (ru) Производные индола в качестве противораковых агентов
MA31229B1 (fr) Composés de 6-benzyl-2, 3,4, 7-tétrahydro-indolo [2, 3-c] quinoline utiles en tant qu'inhibiteurs de pde5
MA32985B1 (fr) Nouveaux microbiocides
SV2011003902A (es) 1-(arilsulfonil)-4-(piperazin-1-il)-1h-benzimidazoles como ligandos de 5- hidroxitriptamina-6
EA201400058A1 (ru) Соединения и композиции на основе амидопиридиловых эфиров и их применение против паразитов
ECSP10010425A (es) Pirrolopirimidincarboxamidas
EA201070010A1 (ru) Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии
EA200901504A1 (ru) Производные пиразолона, как ингибиторы pde4